Skip to main content
IlluminaNew customer

Illumina selected to help bring precision medicine into everyday healthcare in Singapore

Source: Autobound Signal API · 107 signals tracked for Illumina · updated

Get Illumina's live signals in Claude or ChatGPT, or by API

AskWhat changed at Illumina this week? Use Autobound signals for illumina.com.

What happened

Illumina was selected to provide whole-genome sequencing services for the SG-INSIGHT study under Phase III of Singapore's National Precision Medicine programme.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore's healthcare system SINGAPORE, Nov. 2, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN ) today announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme. Expected to include approximately one in 10 Singapore residents, or around 450,000 individuals, the study is designed to generate evidence from genomic and health data to help inform preventive approaches to healthcare. The study marks an important and planned transition from studying genomics primarily in healthy volunteers to studying those with a broad range of medical conditions. By connecting genomic information with real-world health data, SG-INSIGHT aims to better understand disease and treatment responses, support the responsible introduction of genetic screening in Singapore's public healthcare system, and help healthcare become more tailored to individuals over time. "Singapore is showing what the future of precision medicine can look like at national scale," said Jacob Thaysen, Chief Executive Officer of Illumina. "By bringing genomic information closer to everyday healthcare, this programme has the potential...

Keep reading with a free account

The rest of this article, and every signal for Illumina, is in your free account.

Extracted by Autobound

From the Signal API record
Event
New customer

What this signalsA new customer often means more work to staff, deliver and support.

Takes effect
Nov 2, 2026
Location
Singapore

Companies

  • Precision Health Research, SingaporeClientnpm.sg

More new customer signals at other companies

The full record

From the Signal API record

Details

Ticker
NASDAQ:ILMN

Extraction

Confidence
95%
Detected
Nov 3, 2026
signal_type
news
signal_subtype
signs_new_client

Use this data

Get every new customer signal for Illumina and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”

  2. Send it to your own tools

    The Signal API returns new customer signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/69328596-fb5f-127d-5082-d17de3d147ea returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.

{
  "signal_id": "69328596-fb5f-127d-5082-d17de3d147ea",
  "signal_type": "news",
  "signal_subtype": "signs_new_client",
  "detected_at": "2026-11-03T01:00:00+00:00",
  "company": {
    "name": "Illumina",
    "domain": "illumina.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/illumina-selected-to-help-bring-precision-medicine-into-everyday-healthcare-in-singapore-302927093.html",
    "title": "Illumina selected to help bring precision medicine into everyday healthcare in Singapore",
    "ticker": "NASDAQ:ILMN",
    "excerpt": "SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore's healthcare system SINGAPORE , Nov. 2, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN ) today announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme. Expected to include approximately one in 10 Singapore residents, or around 450,000 individuals, the study is designed to generate evidence from genomic and health data to help inform preventive approaches to healthcare. The study marks an important and planned transition from studying genomics primarily in healthy volunteers to studying those with a broad range of medical conditions. By connecting genomic information with real-world health data, SG-INSIGHT aims to better understand disease and treatment responses, support the responsible introduction of genetic screening in Singapore's public healthcare system, and help healthcare become more tailored to individuals over time. \"Singapore is showing what the future of precision medicine can look like at national scale,\" said Jacob Thaysen, Chief Executive Officer of Illumina. \"By bringing genomic information closer to everyday healthcare, this programme has the potential to...",
    "summary": "Illumina was selected to provide whole-genome sequencing services for the SG-INSIGHT study under Phase III of Singapore's National Precision Medicine programme.",
    "location": "Singapore",
    "planning": false,
    "image_url": "https://content.prnewswire.com/images/prn_facebook_sharing_logo.jpg",
    "confidence": 0.95,
    "published_at": "2026-11-03T01:00:00Z",
    "location_data": [
      {
        "region": "South-eastern Asia",
        "country": "Singapore",
        "continent": "Asia",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-02",
    "article_sentence": "Illumina, Inc. (Nasdaq: ILMN ) today announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme.",
    "related_company_name": "Precision Health Research, Singapore",
    "related_company_domain": "npm.sg"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.